Information

Sorry, we couldn't match any information with this search.

What we do

Co-development

Douglas is actively seeking co-development partners who share our commitment to excellence and are looking to bring healthcare solutions to market.

Innovation is at the heart of everything we do at Douglas Pharmaceuticals. Our extensive experience in product development has enabled us to create a portfolio of successful therapies that have made a real difference in patients’ lives.

Douglas has a robust portfolio of innovative projects in various therapeutic areas. We’re seeking co-development partners with complementary expertise and resources to accelerate the development and commercialization of these promising therapies.

Our pipelines

505(j) Complex Generic Pipeline

Douglas has several projects in the pre-formulation or formulation development stage. Douglas specializes in specialty generic product development such as soft-gelatin capsules that have technical, clinical or IP complexity.

For more information on our co-development opportunities, please contact us.

505(b)(2) Pipeline

Douglas specializes in the development of 505(b)(2) alternative formulation products to meet unmet needs in populations of paediatric, geriatric and patients with swallowing difficulties.

We are open to collaboration on these oral liquid opportunities focusing on the US market.

Our success stories

ISOTRETINOIN

Strengths: 5 mg, 10 mg, 20 mg, 30 mg, 40 mg soft-gel capsules
Reference Product: Roaccutane®/Oratane®

For severe forms of nodulo-cystic acne which are resistant to therapy, particularly cystic acne and acne conglobata, especially when the lesions involve the trunk.

ALITRETINOIN

Strengths: 10 mg, 30 mg soft-gel capsules
Reference Product: Toctino®/Zematane®

For treatment of Chronic Hand Eczema – Alitretinoin is indicated for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids.

ACITRETIN

Strengths: 10 mg, 25 mg capsules
Reference Product: Soriatane®/Neotigason®/Novatretin®

For treatment of severe psoriasis – disorders of keratinization, such as ichthyotic disorders, palmoplantar keratoderma, Darier’s disease and lichen planus.

TRETINOIN

Strength: 10 mg soft-gel capsules
Reference Product: Vesanoid®

Used for Acute Promyelocytic Leukaemia – Tretinoin should be used for induction of remission in acute promyelocytic leukaemia (APL; FAB classification AML-M3).

BEXAROTENE

Strength: 75 mg soft-gel capsules
Reference Product: Targretin®

Bexarotene is used to treat Cutaneous T-cell Lymphoma (CTCL, a type of lymphoma that attacks the skin) in people whose disease could not be treated successfully with at least one other medication.

AZATHIOPRINE

Strength: 25, 50, 75, 100 mg filmcoated tablets   

An immunosuppressive medication.

PARICALCITOL

Strength: 1, 2 mcg softgel capsules
Reference Product: Zemplar®

For use in Hyper-parathyroidism – Paricalcitol is indicated in adult and paediatric patients 10 to 16 years of age for the prevention and treatment of secondary hyper-parathyroidism associated with chronic kidney disease Stages 3 and 4.

Why partner with Douglas?

We offer a unique blend of expertise, resources, and a proven track record of success, making us an ideal partner for co-development ventures. Here’s what sets us apart: 

Strong technical capability: With over 58 years of experience in pharmaceutical development, manufacturing, and commercialization, we possess the knowledge and insights to navigate the complexities of the healthcare landscape.

Extensive formulation capability: Douglas is world-known for its softgel formulation, micro dosage capabilities and high potency formulations, but is also experienced in tableting, suspension / solution / syrup / emulsion formulations, semi solids / cream / ointment / gel formulations.

Deep institutional knowledge: The scientists and formulators who developed our products are still on the team at Douglas. This continuity provides an unparalleled depth of understanding and ensures that the original vision for each product is maintained and enhanced.

State-of-the-art facilities: Our GMP-certified manufacturing plant and advanced research laboratories, and access to clinical research trial teams provide the infrastructure necessary to support projects from concept to commercialization. 

Wide networks: We have experience with regulators across the globe and have established a robust distribution network in 40 countries.

Commitment to quality: Douglas is renowned for adherence to the highest international quality standards, ensuring the safety and efficacy of all our products. 

Flexible partnership models: We understand that every project is unique. We offer flexible partnership models tailored to your specific needs and objectives. 

Shared vision: We’re committed to building long-term, mutually beneficial partnerships based on trust, transparency, and open communication. 

Ready to explore a co-development partnership?

Contact us to discuss your project and how we can work together to bring your healthcare innovation to life.

Talk to us today.
Contact us